Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Relenza

Known as: Glaxo Wellcome Brand of Zanamivir, Zanamivir GlaxoSmithKline Brand, Zanamivir Biota Brand 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2013
Highly Cited
2013
Despite scientific and public concern, research on food web contamination from chemicals in plastic is limited, and… Expand
  • figure 2
  • table 1
  • figure 1
  • table 2
  • table 3
2011
2011
Several vaccines are available against pertussis, differing by the number of Bordetella pertussis antigens that they contain as… Expand
  • figure 2
  • figure 3
  • figure 4
2010
2010
Under the International Atomic Energy Agency (IAEA)'s EMRAS (Environmental Modelling for Radiation Safety) programme, activity… Expand
2009
2009
A molecular model of the swine influenza A/H1N1 ( also called H1N1pdm) type-I neuraminidase was built using the pathogenic avian… Expand
Review
2007
Review
2007
GlaxoSmithKline Biologicals (GSK) is committed to the development of a safe and effective malaria vaccine. Its research program… Expand
  • figure 1
2007
2007
The 8 th fascicle (20 numbers) of the exsiccata 'Liche- nicolous Biota' is published. The issue contains material of 20 non… Expand
Highly Cited
2003
Highly Cited
2003
Merozoite Surface Protein-1(42) (MSP-1(42)) is a leading vaccine candidate against erythrocytic malaria parasites. We cloned and… Expand
Highly Cited
2002
Highly Cited
2002
  • Z. Jun
  • 2002
  • Corpus ID: 131944989
On the basis of new biostratigraphic materials recently discovered at the Village Daohugou in the Ningcheng Area, Chifeng City… Expand
2001
2001